搜索

021-65675885

化合物库

Glycogen synthase kinase 3 (GSK3) inhibitor library

 

Glycogen synthase kinase-3 (GSK3) was initially identified more than two decades ago as an enzyme involved in the control of glycogen metabolism. In recent years it has been shown to have key roles in regulating a diverse range of cellular functions, which have prompted efforts to develop GSK3 inhibitors as therapeutics.

GSK3 inhibitors have now been shown to be effective in normalizing blood glucose levels in animal models of type 2 diabetes, with their effects seeming to occur primarily through an increase in hepatic glycogen synthesis and a decrease in hepatic gluconeogenesis.

GSK3 inhibitors might also have potential for neurodegenerative disorders, such as Alzheimer's disease. For example, there is recent evidence that GSK3 increases the production of β-amyloid — which has a key role in the pathogenesis of Alzheimer's disease — and that inhibition of GSK3 might reduce β-amyloid levels.

查看其他分子库

在线客服>>

在线留言x
  • 类型 *
  • 姓名 *
  • 电子邮件 *
  • 手机号码 *
  • 单位名称 *
  • 在线留言 *
河北快三 河北快三 河北快三 河北快三 河北快三 河北快三 河北快三 河北快三 河北快三 河北快三